Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
Part of paid clinical trials in Stanford, California.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT00883688
- Phase
- PHASE2
- Status
- Completed
Conditions
- Brain Cancer
- Pediatric Cancers
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Bevacizumab — DRUG10 mg/kg given by vein over 90 minutes for first injection (30-60 minutes for subsequent doses) every 2 weeks while on study (2 times during each 4-week "study cycle").
- Lapatinib — DRUGPills of 700 mg/m\^2/dose given orally 2 times each day.
Study Details
The goal of this clinical research study is to learn if the combination of Avastin (bevacizumab) and Tykerb (lapatinib) can help to control ependymoma in pediatric patients. The safety of this drug combination will also be studied.
Key Dates
- Start date
- Jul 31, 2009
- Status verified
- Aug 2020
- Primary completion
- Apr 30, 2015
- Completion
- Apr 30, 2015
Study Design
- Enrollment
- 24 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Bevacizumab + LapatinibBevacizumab 10 mg/kg given by vein over 90 minutes for first injection (30-60 minutes for subsequent doses) every 2 weeks while on study (2 times during each 4-week "study cycle"). Lapatinib Pills of 700 mg/m\^2/dose given orally 2 times each day.
Primary Outcome Measure
Objective Response Rate [ Time Frame: 4 weeks following treatment, repeat assessments up to one year. ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University Medical Center | Stanford | California | 94305 | - |
| Children's Memorial Hospital | Chicago | Illinois | 60614 | - |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | - |
| Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | - |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | - |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | - |
Find similar trials in Stanford, CA
By condition
By specialty
By research site
Stanford University Medical Center· Stanford, CAChildren's Memorial Hospital· Chicago, ILCincinnati Children's Hospital Medical Center· Cincinnati, OHChildren's Hospital of Pittsburgh· Pittsburgh, PASt. Jude Children's Research Hospital· Memphis, TNUniversity of Texas MD Anderson Cancer Center· Houston, TX
Related Studies
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- Wearable Devices and Biomarkers Project (Healthiomics)Recruiting · CureScience · San Diego, California
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruiting · Adela, Inc · Duarte, California
- Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)EARLY_PHASE1 · Recruiting · Eben Rosenthal · Nashville, Tennessee